{
  "title": "Paper_536",
  "abstract": "Mol Ther Mol Ther 902 molther Molecular Therapy 1525-0016 1525-0024 American Society of Gene & Cell Therapy PMC11489534 PMC11489534.1 11489534 11489534 39303710 10.1016/j.ymthe.2024.09.013 S1525-0016(24)00599-9 1 Commentary Tumor-intrinsic kinase: A promising target for overcoming resistance to immune checkpoint blockade therapies Wang Jianhui 1 Xia Gaowei 2 Meng Bin 3 Guan Xingang guanxg@ciac.ac.cn 4 ∗ 1 2 3 4 ∗ guanxg@ciac.ac.cn 02 10 2024 20 9 2024 32 10 473117 3209 3210 02 10 2025 02 10 2025 20 10 2024 02 10 2025 © 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. 2024 The American Society of Gene and Cell Therapy pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access no pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes ",
  "metadata": {
    "Title of this paper": "Tumor-intrinsic kinase: A promising target for overcoming resistance to immune checkpoint blockade therapies",
    "Journal it was published in:": "Molecular Therapy",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489534/"
  }
}